European Stocks That May Be Trading Below Their Value In August 2026
As European markets experience a resurgence in risk appetite and resilient earnings, investors are keenly observing the potential impact of geopolitical developments on stock valuations. Amidst this backdrop, identifying stocks that may be trading below their intrinsic value becomes crucial for those looking to capitalize on market inefficiencies.
Top 10 Undervalued Stocks Based On Cash Flows In Europe
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| ZEAL Network (XTRA:TIMA) | €43.90 | €86.99 | 49.5% |
| Vitrolife (OM:VITR) | SEK91.85 | SEK181.79 | 49.5% |
| New Wave Group (OM:NEWA B) | SEK93.05 | SEK182.52 | 49% |
| Murapol (WSE:MUR) | PLN39.10 | PLN77.58 | 49.6% |
| Koskisen Oyj (HLSE:KOSKI) | €8.56 | €16.93 | 49.4% |
| ISS (CPSE:ISS) | DKK291.00 | DKK566.99 | 48.7% |
| Dynavox Group (OM:DYVOX) | SEK76.35 | SEK149.01 | 48.8% |
| Diagnostic Medical Systems (ENXTPA:ALDMS) | €1.08 | €2.13 | 49.4% |
| DEUTZ (XTRA:DEZ) | €10.23 | €20.18 | 49.3% |
| Borregaard (OB:BRG) | NOK156.60 | NOK308.79 | 49.3% |
Below we spotlight a couple of our favorites from our exclusive screener.
RaySearch Laboratories (OM:RAY B)
Overview: RaySearch Laboratories AB (publ) is a medical technology company that provides software solutions for cancer treatment globally, with a market cap of approximately SEK6.45 billion.
Operations: RaySearch Laboratories AB (publ) generates revenue from its global software solutions designed for cancer treatment.
Estimated Discount To Fair Value: 46.1%
RaySearch Laboratories appears undervalued, trading at SEK188.2, significantly below its estimated future cash flow value of SEK349.43. Despite a 2.13% dividend yield not well-covered by free cash flows, earnings have grown substantially at 64.5% annually over five years and are expected to continue growing faster than the Swedish market at 18.6% per year. Recent earnings showed a decline in sales and net income compared to last year, but expansion in advanced proton therapy capabilities could enhance future revenue streams.
- Our growth report here indicates RaySearch Laboratories may be poised for an improving outlook.
- Get an in-depth perspective on RaySearch Laboratories' balance sheet by reading our health report here.
Kardex Holding (SWX:KARN)
Overview: Kardex Holding AG offers intralogistics solutions across Europe, the Middle East, Africa, the Americas, and the Asia Pacific with a market cap of CHF1.97 billion.
Operations: The company's revenue is derived from two main segments: Automated Products, which generated €541.30 million, and Standardized Systems, contributing €334.80 million.
Estimated Discount To Fair Value: 32.7%
Kardex Holding is trading at CHF255.5, significantly below its estimated future cash flow value of CHF379.72, suggesting it may be undervalued based on cash flows. Despite a volatile share price and profit margins declining to 3.2% from 9.4% last year, earnings are forecast to grow substantially at over 40% annually, outpacing the Swiss market's growth rate. Recent guidance anticipates revenue growth between 15%-20%, although net income dropped to EUR22.6 million for the half-year ending June 2026 compared to EUR36.2 million previously.
- In light of our recent growth report, it seems possible that Kardex Holding's financial performance will exceed current levels.
- Take a closer look at Kardex Holding's balance sheet health here in our report.
Delivery Hero (XTRA:DHER)
Overview: Delivery Hero SE offers online food ordering, quick commerce, and delivery services with a market cap of €11.27 billion.
Operations: The company's revenue segments include €4.42 billion from Asia, €2.49 billion from Europe, €1.06 billion from the Americas, and €4.03 billion from MENA (Middle East and North Africa), along with €3.19 billion generated through Integrated Verticals.
Estimated Discount To Fair Value: 40.5%
Delivery Hero, trading at €37.1, is valued below its estimated future cash flow value of €62.38, indicating potential undervaluation based on cash flows. The company's revenue is projected to grow at 9.2% annually, surpassing the German market's growth rate of 6.6%. Recent M&A activity includes Uber Technologies' proposal to acquire a significant stake in Delivery Hero for €8.4 billion, potentially enhancing its strategic positioning and financial performance upon completion in the second half of 2027.
- Insights from our recent growth report point to a promising forecast for Delivery Hero's business outlook.
- Unlock comprehensive insights into our analysis of Delivery Hero stock in this financial health report.
Turning Ideas Into Actions
- Unlock more gems! Our Undervalued European Stocks Based On Cash Flows screener has unearthed 213 more companies for you to explore.Click here to unveil our expertly curated list of 216 Undervalued European Stocks Based On Cash Flows.
- Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
- Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Interested In Other Possibilities?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com